Product Reports Resources Pricing Login Book a demo

Biorce

Biotech & Life Sciences · Barcelona, Spain · Founded 2024

Revolutionizing drug development through the power of artificial intelligence for clinical trials MoreLess

Biorce is a pioneering Deeptech company dedicated to revolutionizing drug development through the power of artificial intelligence (AI). We are passionate about accelerating medical advancements and improving patient outcomes.

Our team comprises seasoned clinical research professionals, data scientists, and AI experts, working collaboratively to bridge the gap between cutting-edge technology and real-world clinical needs.

With an unwavering commitment to revolutionize healthcare, Biorce envisions a world where all patients benefit from accelerated and cost-effective access to treatments. Our flagship product, Jarvis, stands as the pioneer Clinical AI assistant, granting universal access to clinical data at one's fingertips. Biorce is poised to redefine the landscape of healthcare, shaping a future where innovation and accessibility converge for the betterment of humanity.

Join us in our mission to make a positive impact on healthcare.

Company overview

Biorce company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2024
Headquarters
Barcelona, Spain
Employees
140
Open positions
89
Dealroom signal
94.7
client focusb2btechnologyArtificial IntelligencetechnologyDeep Techsub industryPharmaceuticalsub industryHealth Platformbusiness modelSaaSindustryHealthsectorBiotechnologysectorDrug DevelopmentsectorCore AIsectorClinical TrialssectorTech for Biotech and PharmasectorTechbiosectorTechbio Drug Discovery

Valuation & funding

Biorce funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Feb 2026 $52M $208M Norrsken VC · Mustard Seed MAZE · YZR Capital · Arthur Mensch
SEEDOther financing Jul 2025 $5.5M $22M Norrsken VC
SUPPORT PROGRAMOther financing Dec 2024 $0 Google for Startups Accelerator
SEEDOther financing Nov 2024 $3.9M $15M Plug and Play · Outsized Ventures · Mustard Seed MAZE · YZR Capital
Showing 4 recorded eventsUnlock the complete deal history →

Growth signals

Biorce website traffic

Latest recorded traffic for Biorce is 15K monthly website visits, down 31.8% over the last three months. Biorce's team grew 677.8% over the past year.

Latest monthly visits15K 3-month web change-31.8% 1-year team growth+677.8%
Monthly website visits19 observations · Oct 2024–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Biorce compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Biorce's talent

Book a demo to see the people
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

11 investors on Biorce's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 5 investors entered at this stage
Mustard Seed MAZE
YZR Capital
Plug and Play
Outsized Ventures
Norrsken VC
Series A 5 investors entered at this stage
DST Global
Arthur Mensch
Nikolay Storonsky
Paulo Rosado
Albert Nieto
Other known 1 additional known investor
Google for Startups Accelerator

Global footprint

Where Biorce has talent and traffic

Workforce by country
5 countries with
team presence
🇪🇸 Spain69.6%
🇺🇸 United States14.1%
🇵🇹 Portugal8.7%
🇬🇧 United Kingdom6.5%
🇩🇪 Germany1.1%
5 countries shown

In the news

Latest news about Biorce

Recent press, funding announcements, and product moves mentioning Biorce — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Biorce

An AI-synthesized read of the highest-engagement posts about Biorce on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Biorce’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.